Nava Therapeutics

Nava Therapeutics is a life-sciences company developing lipid nanoparticle (LNP) technology for delivering RNA therapeutics precisely to specific organs and cells, aiming to extend genetic medicines to previously untreatable diseases. Surfaced as a portfolio company of GV (Google Ventures) and added to the API Evangelist network, Nava operates in the therapeutics / RNA-delivery sector and, as a private clinical-stage biotech, publishes a corporate marketing site (pipeline, team, newsroom) but no public developer, API, or integration surface at this time.

Nava Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Life Sciences, Biotechnology, Therapeutics, and RNA Delivery.

Nava Therapeutics’ developer surface includes engineering blog and 3 more developer resources.

🌐 Visit website 📡 Source on GitHub
11.2/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyLife SciencesBiotechnologyTherapeuticsRNA DeliveryLipid NanoparticlesGenetic Medicine

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 11.2/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.4 / 20
Commercial Clarity 2.1 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/nava-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Nava Therapeutics Domain Security

TLSv1.3 · HSTS · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Commercial 1

Pricing, plans, and the legal terms of use

PrivacyPolicy
PrivacyPolicy

Company 2

The organization behind the API

Website
Website
 Blog
Blog

Source (apis.yml)

apis.yml Raw ↑ 
aid: nava-therapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/nava-therapeutics.png
name: Nava Therapeutics
description: Nava Therapeutics is a life-sciences company developing lipid nanoparticle (LNP) technology for delivering RNA
  therapeutics precisely to specific organs and cells, aiming to extend genetic medicines to previously untreatable diseases.
  Surfaced as a portfolio company of GV (Google Ventures) and added to the API Evangelist network, Nava operates in the therapeutics
  / RNA-delivery sector and, as a private clinical-stage biotech, publishes a corporate marketing site (pipeline, team, newsroom)
  but no public developer, API, or integration surface at this time.
url: https://raw.githubusercontent.com/api-evangelist/nava-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- gv
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Life Sciences
- Biotechnology
- Therapeutics
- RNA Delivery
- Lipid Nanoparticles
- Genetic Medicine
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/nava-therapeutics-domain-security.yml
- type: Website
  url: https://navatx.com
- type: Blog
  name: Newsroom
  url: https://navatx.com/newsroom/
- type: PrivacyPolicy
  url: https://navatx.com/privacy-policy/
x-enrichment:
  date: '2026-07-20'
  status: nochange
  artifacts_added: 0
  pass: local-v1